Neocis develops robot-assisted dental implant surgery with the aim of transforming dental surgery using advanced robotics.
Neocis develops robot-assisted dental implant surgery with the aim of transforming dental surgery using advanced robotics. The company is the developer and manufacturer of Yomi, a robotic device for dental surgery commercially available in the USA and was cleared by the U.S. Food and Drug Administration. The company created Yomi aiming to focus on enhancing dental surgeons’ capabilities and advancing patient care through the latest technology. Neocis operates with dental surgeons to understand the needs with the focus on overcoming surgical and treatment challenges. Neocis was founded in 2009 and is headquartered in Miami, Florida.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 27, 2022 | Series D | $40M | 7 | — | — | Detail |
Oct 8, 2020 | Series D | $72M | 6 | DFJ Growth | — | Detail |
Jul 15, 2019 | Series Unknown | $30M | 2 | Norwest Venture Partners Mithril Capital Management | — | Detail |
Jul 11, 2017 | Grant | $225K | 1 | National Science Foundation | — | Detail |
Jun 29, 2017 | Series Unknown | $15M | — | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |
Propel(X) | Yes | Series B |
Norwest Venture Partners | — | Series D |
DFJ Growth | — | Series D |
Fred Moll | — | Series D |
Intuitive Ventures | — | Series D |
Mithril Capital Management | — | Series D |
Section 32 | — | Series D |
Vivo Capital | — | Series D |
Fred Moll, M.D | — | Series D |